Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study

BACKGROUND: Recent advances in Hepatitis C therapeutics offer the possibility of cure but will be expensive. The cost of treatment may be partially offset by the avoidance of advanced liver disease. We performed a micro-costing study of the ambulatory healthcare utilisation of patients with Hepatiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kieran, Jennifer Ann, Norris, Suzanne, O’Leary, Aisling, Walsh, Cathal, Merriman, Raphael, Houlihan, D., McCormick, P. Aiden, McKiernan, Susan, Bergin, Colm, Barry, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624167/
https://www.ncbi.nlm.nih.gov/pubmed/26503519
http://dx.doi.org/10.1186/s12879-015-1208-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624167/
https://www.ncbi.nlm.nih.gov/pubmed/26503519
http://dx.doi.org/10.1186/s12879-015-1208-1

Ejemplares similares